Results 201 to 210 of about 1,333,671 (322)

Environmental endocrine disruptors and endometrial cancer: a systematic review of epidemiological studies. [PDF]

Front Endocrinol (Lausanne)
Incognito D, Gelsomino C, Picone A, Ettore G, Ettore C, Incognito GG, Di Mauro G, Santarpia M, Aguennouz M, Parisi S, Ciappina G, Berretta M.   +11 more
europepmc   +1 more source

Allogeneic Immune Cell Perfusion Inhibits the Growth of Vascularized 3D In Vitro Tumor Models, Induces Vascular Regression and Desmoplasia, but Promotes Tumor Cell Invasion

Advanced Science, EarlyView.
This study presents a vascularized 3D tumor model to investigate immune–stromal–tumor interactions under allogeneic PBMC perfusion. While immune cells induced tumor shrinkage, they also promoted vascular regression, stromal activation, and cancer cell invasion.
Alexandra Raab, Rasika Daware, Marcelo A. Szymanski de Toledo, Oskar Weber, Dimitris Kapsokalyvas, Twan Lammers, Horst Fischer, Federica De Lorenzi, Fabian Kiessling   +8 more
wiley   +1 more source

Impact of endocrine disruptors on female fertility: an update. [PDF]

Ann Med Surg (Lond)
Tague C, Makeda D, Yokolo H, Ekouo J, Tatsadjieu Ngoune LS, Onesime J, Banga S, Kashafali A, Akilimali A.   +8 more
europepmc   +1 more source

IGF‐1 Deficiency Serves as an Integrated Biomarker Pathogenic Driver and Predictor in Poor Ovarian Response

Advanced Science, EarlyView.
IGF‐1 deficiency underlies poor ovarian response (POR), as reduced levels in follicular fluid and granulosa cells impair antral follicle formation and compromise reproductive outcomes. Including IGF‐1 as a biomarker significantly enhances the accuracy of models predicting both PORrisk and pregnancy success.
Zhu Hu, Yuanyuan Yu, Guanyou Huang, Jinnan Li, Chao Yang, Aizhuan Long, Jia Tang, Tengxiang Chen, Shuyun Zhao, Tuo Zhang   +9 more
wiley   +1 more source

Endocrine Disruptors and Breast Cancer: A Comprehensive Review. [PDF]

Biomedicines
Czaczkowska L, Jabłońska E, Ratajczak-Wrona W.   +2 more
europepmc   +1 more source

Ufmylation‐Deficient DDRGK1 Ameliorates Obesity by Inhibiting FASN‐Mediated Adipocyte Lipogenesis

Advanced Science, EarlyView.
DDRGK1 regulates de novo lipogenesis via stabilization of fatty acid synthase (FASN). DDRGK1‐mediated UFMylation of FASN prevents its ubiquitin–proteasomal degradation. Reduced DDRGK1 expression or mutation at the key UFMylation site enhances FASN degradation and suppresses fatty acid synthesis (FAS), resulting in smaller adipocytes and improved ...
Yin Li, Tangjun Zhou, Xiao Yang, Kewei Rong, Xiankun Cao, Lei Shi, Xin Wang, Hongjin Wan, Lei Cui, Kexin Liu, Tong Xing, Hang Zhang, Chen Zhao, Tingxian Guo, Peixiang Ma, Jie Zhao, An Qin   +16 more
wiley   +1 more source

A systematic review of exposure to endocrine disruptors and energy expenditure in mice. [PDF]

Environ Health
Dos Santos Rodrigues Vaz ML, da Silva Sousa AB, Ribeiro CM, Bellozi PMQ, Amato AA.   +4 more
europepmc   +1 more source

Road to regulation of endocrine disruptors and combination effects [PDF]

, 2014
Lindeman, Birgitte, Petersen, Karina
core   +1 more source

Sulfakinin Signaling Sense Circulating Fructose and Suppresses Food Consumption via Insulin‐Like Peptide in Bactrocera Dorsalis

Advanced Science, EarlyView.
This study discovered a new pathway that tells fruit flies when to stop eating. It found that rising blood sugar (fructose) is detected by a sensor called GR43a. This triggers a chain reaction involving the satiety signal sulfakinin and its receptor, ultimately activating a final satiety signal, ILP5.
Hong‐Fei Li, Bao Dong, Zheng‐Lin Ren, Xue‐Guang Zhu, Quan Lei, Yoonseong Park, Jin‐Jun Wang, Hong‐Bo Jiang   +7 more
wiley   +1 more source

Effects of endocrine disruptors on thyroid function: consequences of fetal exposure. [PDF]

Turk J Med Sci
Eraslan Aydemir E, Şahin M.
europepmc   +1 more source